Skip to content

Iris Acquisition IRAB Deferred Offering Costs Non Current

Deferred Offering Costs Non Current at other companies

KRAKacquisition
 logo
KRAKacquisition KRAQ
$436.02K
Enliven Therapeutics logo
Enliven TherapeuticsELVN
$217K
FCR
FutureCrest Acquisition FCRS
$12.25M
Annexon logo
AnnexonANNX
$445K+449%
Bain Capital Specialty Finance logo
Bain Capital Specialty FinanceBCSF
$3.29M-24.2%
Strawberry Fields logo
Strawberry FieldsSTRW
$2M

Other financials

Income statement

See full
Operating income-$144.1K
Net income$773.9K

Balance sheet

See full
Cash & equivalents$854.8K
Total debt$84.6K
Total equity-$6.4M
Total assets$170.4M

Cash flow

See full
Operating cash flow-$9.8K

Valuation

See full
Market cap$227.44M+0.2%
Enterprise value$226.67M

Returns & leverage

See full
Debt / equity-0×
Current ratio2.9×

Where this comes from

Reported directly by Iris Acquisition in its filing.

Tagged under the XBRL concept iraa:DeferredOfferingCostsNonCurrent.

The official record: Iris Acquisition ’s 10-K, filed March 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about Iris Acquisition 's deferred offering costs non current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Iris Acquisition 's deferred offering costs non current?
Iris Acquisition (IRAB) reported deferred offering costs non current of $139.6K in Q4 2025.
What does deferred offering costs non current mean?
Represents costs directly attributable to the issuance of equity securities that are capitalized and amortized over the life of the instrument. These costs are classified as non-current when the expected benefit or amortization period extends beyond one year. This metric is critical for SPACs to track the accumulation of IPO-related expenses before they are offset against equity proceeds.